Go Pro
→ Bank of America: 'Digital Dollar Inevitable' (From Decentralized Masters) (Ad)tc pixel Free VCKAW Stock Alerts

Vickers Vantage Corp. I (VCKAW) Competitors

$0.12 0.00 (-3.98%)
As of 09/4/2026
Compare

VCKAW vs. SXTPW, BFRIW, CINGW, CLVR, and CMRAW

Should you buy Vickers Vantage Corp. I stock or one of its competitors? Vickers Vantage Corp. I's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Cingulate (CINGW), Clever Leaves (CLVR), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Vickers Vantage Corp. I compare to 60 Degrees Pharmaceuticals?

Vickers Vantage Corp. I (NASDAQ:VCKAW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership.

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Vickers Vantage Corp. I. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Vickers Vantage Corp. I. 60 Degrees Pharmaceuticals' average media sentiment score of 1.99 beat Vickers Vantage Corp. I's score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Vickers Vantage Corp. I Neutral
60 Degrees Pharmaceuticals Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vickers Vantage Corp. IN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Vickers Vantage Corp. IN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

Summary

60 Degrees Pharmaceuticals beats Vickers Vantage Corp. I on 3 of the 3 factors compared between the two stocks.

How does Vickers Vantage Corp. I compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Vickers Vantage Corp. I (NASDAQ:VCKAW) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$46.18MN/AN/AN/AN/A
Vickers Vantage Corp. IN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Vickers Vantage Corp. I N/A N/A N/A

In the previous week, Biofrontera's average media sentiment score of 0.00 equaled Vickers Vantage Corp. I'saverage media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
Vickers Vantage Corp. I Neutral

Summary

Biofrontera beats Vickers Vantage Corp. I on 1 of the 1 factors compared between the two stocks.

How does Vickers Vantage Corp. I compare to Cingulate?

Cingulate (NASDAQ:CINGW) and Vickers Vantage Corp. I (NASDAQ:VCKAW) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

Company Net Margins Return on Equity Return on Assets
CingulateN/A N/A N/A
Vickers Vantage Corp. I N/A N/A N/A

In the previous week, Cingulate's average media sentiment score of 0.00 equaled Vickers Vantage Corp. I'saverage media sentiment score.

Company Overall Sentiment
Cingulate Neutral
Vickers Vantage Corp. I Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CingulateN/AN/AN/AN/AN/A
Vickers Vantage Corp. IN/AN/AN/AN/AN/A

Summary

Cingulate and Vickers Vantage Corp. I tied by winning 0 of the 0 factors compared between the two stocks.

How does Vickers Vantage Corp. I compare to Clever Leaves?

Clever Leaves (NASDAQ:CLVR) and Vickers Vantage Corp. I (NASDAQ:VCKAW) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

In the previous week, Clever Leaves' average media sentiment score of 0.00 equaled Vickers Vantage Corp. I'saverage media sentiment score.

Company Overall Sentiment
Clever Leaves Neutral
Vickers Vantage Corp. I Neutral

Vickers Vantage Corp. I has lower revenue, but higher earnings than Clever Leaves.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clever Leaves$17.42M0.00-$17.90M-$9.66N/A
Vickers Vantage Corp. IN/AN/AN/AN/AN/A

6.9% of Clever Leaves shares are owned by institutional investors. 8.2% of Clever Leaves shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
Clever LeavesN/A N/A N/A
Vickers Vantage Corp. I N/A N/A N/A

Summary

Clever Leaves beats Vickers Vantage Corp. I on 3 of the 3 factors compared between the two stocks.

How does Vickers Vantage Corp. I compare to Comera Life Sciences?

Vickers Vantage Corp. I (NASDAQ:VCKAW) and Comera Life Sciences (NASDAQ:CMRAW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, dividends, profitability and institutional ownership.

Company Net Margins Return on Equity Return on Assets
Vickers Vantage Corp. IN/A N/A N/A
Comera Life Sciences N/A N/A N/A

In the previous week, Vickers Vantage Corp. I's average media sentiment score of 0.00 equaled Comera Life Sciences'average media sentiment score.

Company Overall Sentiment
Vickers Vantage Corp. I Neutral
Comera Life Sciences Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vickers Vantage Corp. IN/AN/AN/AN/AN/A
Comera Life Sciences$1.00MN/AN/AN/AN/A

Summary

Comera Life Sciences beats Vickers Vantage Corp. I on 1 of the 1 factors compared between the two stocks.

Get Vickers Vantage Corp. I News Delivered to You Automatically

Sign up to receive the latest news and ratings for VCKAW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VCKAW vs. The Competition

Export
MetricVickers Vantage Corp. IPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$11.86B$7.04B$12.87B
Dividend YieldN/A2.59%2.54%9.14%
P/E RatioN/A784.68271.1525.40
Price / SalesN/A790.59632.7493.46
Price / CashN/A15.1828.9235.62
Price / BookN/A11.0010.926.42
Net IncomeN/A$2.81B$3.48B$358.18M
7 Day Performance-10.92%-0.12%-0.02%0.69%
1 Month PerformanceN/A4.34%3.02%-0.78%
1 Year Performance-73.39%7.58%22.73%13.38%

Vickers Vantage Corp. I Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VCKAW
Vickers Vantage Corp. I
N/A$0.12
-4.0%		N/A-73.4%$0.00N/AN/AN/A
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
-5.3%		N/A-50.7%$0.00$1.11MN/A2
BFRIW
Biofrontera
N/A$0.03
-12.0%		N/A-80.0%$0.00$46.18MN/A70
CINGW
Cingulate
N/A$0.01
-20.5%		N/A-83.7%$0.00N/AN/A20
CLVR
Clever Leaves
N/A$0.00
flat		N/AN/A$0.00$17.42MN/A560

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:VCKAW) was last updated on 9/8/2026 by MarketBeat.com Staff.
From Our Partners
This looks like plywood. It's not.
AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...
Eagle Publishing | Sponsoredtc pixel
Musk just exposed the crack in his empire
SpaceX's IPO raised approximately $85.7 billion in gross proceeds. Days later, the company revealed its combin...
The Oxford Club | Sponsoredtc pixel
They're not buying gold. They're buying this.
Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, ...
Behind the Markets | Sponsoredtc pixel
SpaceX pays a 10X launch penalty
SpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...
Freedom Financial | Sponsoredtc pixel
Jon Najarian's #1 Energy Trade for 2026
Jon Najarian says he's never been more excited about an energy opportunity. SpaceX just went public at over $2...
Banyan Hill Publishing | Sponsoredtc pixel
BlackRock and Vanguard already own THIS
Institutions own roughly 88 percent of an overlooked American oil and natural gas company. BlackRock holds 32 ...
Monument Traders Alliance | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel